News

• 1/26/10
  Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
  <<click here for release>>

• 12/16/09
  Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
  <<click here for release>>

News & Events

1/26/10

Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Neuroscience Industry Veteran to Lead Development of Chronic Pain Treatments; Technology Targets Novel Biological Pathway
<<click here for release>>

12/16/09

Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Pappas, Third Rock, Domain and New Leaf Launch New Company Centered on Novel Pain Management Technology; Afferent to Initiate Clinical Trials in First Half of 2010
<<click here for release>>